Global Migraine Headache Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Migraine Headache Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Migraine treatment usually is with over-the-counter (OTC) migraine medication or prescription drugs.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.
Migraine Headache Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Migraine Headache Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Acute Migraine and Common Migraine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Migraine Headache Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Migraine Headache Drugs key companies include Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca and Sun Pharma, etc. Pfizer, Novartis, Johnson & Johnson are top 3 players and held % share in total in 2022.
Migraine Headache Drugs can be divided into Almotriptan, Eletriptan, Sumatriptan and Rizatriptan, etc. Almotriptan is the mainstream product in the market, accounting for % share globally in 2022.
Migraine Headache Drugs is widely used in various fields, such as Acute Migraine, Common Migraine, Classic Migraine and Chronic Migraine, etc. Acute Migraine provides greatest supports to the Migraine Headache Drugs industry development. In 2022, global % share of Migraine Headache Drugs went into Acute Migraine filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Migraine Headache Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
Segment by Type
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Migraine Headache Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Migraine Headache Drugs introduction, etc. Migraine Headache Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Migraine Headache Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Migraines, this type of headache often involves only one side of the head, but in some cases, patients may have pain bilaterally or on both sides. Migraine headache is a result of specific changes within the brain. It causes severe head pain that is often accompanied by sensitivity to light, sound, or smells.
Migraine Headache Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Migraine Headache Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Acute Migraine and Common Migraine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Migraine Headache Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Migraine Headache Drugs key companies include Pfizer, Novartis, Johnson & Johnson, GSK, Merck, Eli Lilly, Teva, AstraZeneca and Sun Pharma, etc. Pfizer, Novartis, Johnson & Johnson are top 3 players and held % share in total in 2022.
Migraine Headache Drugs can be divided into Almotriptan, Eletriptan, Sumatriptan and Rizatriptan, etc. Almotriptan is the mainstream product in the market, accounting for % share globally in 2022.
Migraine Headache Drugs is widely used in various fields, such as Acute Migraine, Common Migraine, Classic Migraine and Chronic Migraine, etc. Acute Migraine provides greatest supports to the Migraine Headache Drugs industry development. In 2022, global % share of Migraine Headache Drugs went into Acute Migraine filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Migraine Headache Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer
Novartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
Segment by Type
Almotriptan
Eletriptan
Sumatriptan
Rizatriptan
Zolmitriptan
Naratriptan
Frovatriptan
Others
Segment by Application
Acute Migraine
Common Migraine
Classic Migraine
Chronic Migraine
Other Migraines
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Migraine Headache Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Migraine Headache Drugs introduction, etc. Migraine Headache Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Migraine Headache Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices